New Study Demonstrates Efficacy

Read more about ERX-41 in this recent publication in Nature Cancer from the lab of etiraRx founder Ganesh Raj: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress.